PYPD · Forms 3, 4, 5

Insider trades at PolyPid Ltd.

No open-market insider buys or sells at PolyPid Ltd. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.

Every Form 3, 4 and 5 filed for PolyPid Ltd. (PYPD) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.

Most recent insider filings

No Form 3, 4 or 5 filings for PolyPid Ltd. in the last 90 days. The latest ones on EDGAR:

DateInsiderRoleTransactionSharesPriceValueFiling
Ori WarshavskyChief Operating Officer - USOptions or other derivativesForm 4
Jonathan MissulawinChief Financial OfficerOptions or other derivativesForm 4
Dalit Fellous HazanDeputy CEO, EVP, RD, CRAOptions or other derivativesForm 4
Yechezkel BarenholzDirectorOptions or other derivativesForm 4
Robert Benjamin SteinDirectorOptions or other derivativesForm 4
Nir Dror-DarwishDirectorOptions or other derivativesForm 4
Joseph BenAmramDirectorOptions or other derivativesForm 4
Itzhak KrinskyDirectorOptions or other derivativesForm 4
Brooke StoryDirectorOptions or other derivativesForm 4
Dikla Czaczkes AkselbradChief Executive OfficerOptions or other derivativesForm 4

Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.